Oncopeptides AB (publ) (ONCO.ST)

SEK 1.54

(1.18%)

Total Assets Summary of Oncopeptides AB (publ)

  • Oncopeptides AB (publ)'s latest annual total assets in 2023 was 238.37 Million SEK , down -38.14% from previous year.
  • Oncopeptides AB (publ)'s latest quarterly total assets in 2024 Q2 was 452.92 Million SEK , up 126.81% from previous quarter.
  • Oncopeptides AB (publ) reported annual total assets of 385.32 Million SEK in 2022, down -12.3% from previous year.
  • Oncopeptides AB (publ) reported annual total assets of 439.37 Million SEK in 2021, down -53.59% from previous year.
  • Oncopeptides AB (publ) reported quarterly total assets of 199.69 Million SEK for 2024 Q1, down -16.23% from previous quarter.
  • Oncopeptides AB (publ) reported quarterly total assets of 355.99 Million SEK for 2023 Q2, up 12.34% from previous quarter.

Annual Total Assets Chart of Oncopeptides AB (publ) (2023 - 2014)

Historical Annual Total Assets of Oncopeptides AB (publ) (2023 - 2014)

Year Total Assets Total Assets Growth
2023 238.37 Million SEK -38.14%
2022 385.32 Million SEK -12.3%
2021 439.37 Million SEK -53.59%
2020 946.75 Million SEK -4.7%
2019 993.48 Million SEK 123.49%
2018 444.53 Million SEK -7.36%
2017 479.82 Million SEK 762.48%
2016 55.63 Million SEK 1163.8%
2015 4.4 Million SEK -66.46%
2014 13.12 Million SEK 0.0%

Peer Total Assets Comparison of Oncopeptides AB (publ)

Name Total Assets Total Assets Difference
Alligator Bioscience AB (publ) 118.45 Million SEK -101.248%
Ziccum AB (publ) 14.97 Million SEK -1492.159%
Modus Therapeutics Holding AB (publ) 20.04 Million SEK -1089.452%
BioArctic AB (publ) 1.18 Billion SEK 79.902%
Sprint Bioscience AB (publ) 62.37 Million SEK -282.157%
Mendus AB (publ) 755.95 Million SEK 68.467%
Genovis AB (publ.) 288.85 Million SEK 17.475%
Intervacc AB (publ) 259.61 Million SEK 8.179%
QuiaPEG Pharmaceuticals Holding AB (publ) 41.95 Million SEK -468.121%
Active Biotech AB (publ) 44 Million SEK -441.768%
Magle Chemoswed Holding AB (publ) 278.74 Million SEK 14.482%
Bio-Works Technologies AB (publ) 62.15 Million SEK -283.54%
Aptahem AB (publ) 63.02 Million SEK -278.228%
Vicore Pharma Holding AB (publ) 496.24 Million SEK 51.964%
Kancera AB (publ) 65.64 Million SEK -263.143%
Infant Bacterial Therapeutics AB (publ) 351.33 Million SEK 32.151%
Fluicell AB (publ) 9.34 Million SEK -2452.227%
Saniona AB (publ) 64.14 Million SEK -271.635%
Lipigon Pharmaceuticals AB (publ) 33.6 Million SEK -609.416%
Biovica International AB (publ) 131.4 Million SEK -81.403%
Spago Nanomedical AB (publ) 52.98 Million SEK -349.897%
AcouSort AB (publ) 34.51 Million SEK -590.69%
Xintela AB (publ) 18.39 Million SEK -1195.885%
Abliva AB (publ) 87.49 Million SEK -172.435%
Egetis Therapeutics AB (publ) 760.2 Million SEK 68.643%
Karolinska Development AB (publ) 1.25 Billion SEK 81.057%
OncoZenge AB (publ) 20.34 Million SEK -1071.967%
Amniotics AB (publ) 26.08 Million SEK -813.816%
2cureX AB (publ) 16.62 Million SEK -1333.853%
CombiGene AB (publ) 120.61 Million SEK -97.64%
Asarina Pharma AB (publ) 6.07 Million SEK -3822.626%
Calliditas Therapeutics AB (publ) 1.9 Billion SEK 87.457%
Camurus AB (publ) 1.9 Billion SEK 87.505%
Corline Biomedical AB 100.1 Million SEK -138.128%
IRLAB Therapeutics AB (publ) 177.12 Million SEK -34.585%
Isofol Medical AB (publ) 140.59 Million SEK -69.547%
I-Tech AB 152.44 Million SEK -56.372%
Hansa Biopharma AB (publ) 1.01 Billion SEK 76.585%
Cyxone AB (publ) 43.65 Million SEK -446.05%
ExpreS2ion Biotech Holding AB (publ) 78.69 Million SEK -202.925%
Biosergen AB 7.2 Million SEK -3210.346%
Cantargia AB (publ) 223.71 Million SEK -6.556%
NextCell Pharma AB 81.28 Million SEK -193.251%
Xspray Pharma AB (publ) 765.26 Million SEK 68.85%
Elicera Therapeutics AB (publ) 30.17 Million SEK -690.037%
Nanologica AB (publ) 77.42 Million SEK -207.867%
SynAct Pharma AB 228.01 Million SEK -4.543%
Annexin Pharmaceuticals AB (publ) 26.76 Million SEK -790.7%
Stayble Therapeutics AB (publ) 21.7 Million SEK -998.371%
LIDDS AB (publ) 17.65 Million SEK -1250.201%
Lipum AB (publ) 12.11 Million SEK -1868.439%
BioInvent International AB (publ) 1.4 Billion SEK 82.975%
Alzinova AB (publ) 123.18 Million SEK -93.506%
Pila Pharma AB (publ) 8.45 Million SEK -2719.373%
Guard Therapeutics International AB (publ) 85.22 Million SEK -179.698%
Scandinavian ChemoTech AB (publ) 14.86 Million SEK -1503.188%
Simris Alg AB (publ) 174.55 Million SEK -36.566%
Diamyd Medical AB (publ) 217.03 Million SEK -9.832%
Xbrane Biopharma AB (publ) 653.5 Million SEK 63.523%
Ascelia Pharma AB (publ) 87.07 Million SEK -173.771%
Diagonal Bio AB (publ) 28.5 Million SEK -736.179%